dapivirine ring

European Medicines Agency (EMA) approval of the dapivirine ring for HIV prevention for women in high HIV burden settings

The European Medicines Agency (EMA) announced today that its human medicines committee (CHMP) provided a positive benefit-risk opinion on the use of the Dapivirine Vaginal Ring (DPV-VR) for HIV prevention.